BRENNTAG AG/ADR (OTCMKTS:BNTGY) Downgraded by Deutsche Bank

Share on StockTwits

BRENNTAG AG/ADR (OTCMKTS:BNTGY) was downgraded by equities research analysts at Deutsche Bank from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, The Fly reports.

BNTGY has been the topic of several other reports. Zacks Investment Research upgraded BRENNTAG AG/ADR from a “sell” rating to a “hold” rating in a research note on Friday, August 16th. ValuEngine cut BRENNTAG AG/ADR from a “hold” rating to a “sell” rating in a research report on Monday, November 25th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $12.00.

Shares of OTCMKTS BNTGY opened at $10.47 on Monday. The stock has a fifty day simple moving average of $10.28 and a two-hundred day simple moving average of $9.83. BRENNTAG AG/ADR has a 1-year low of $8.20 and a 1-year high of $10.96. The firm has a market cap of $8.09 billion, a price-to-earnings ratio of 14.96, a price-to-earnings-growth ratio of 1.82 and a beta of 1.28. The company has a current ratio of 1.75, a quick ratio of 1.18 and a debt-to-equity ratio of 0.09.

About BRENNTAG AG/ADR

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Featured Story: What is a Special Dividend?

The Fly

Receive News & Ratings for BRENNTAG AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRENNTAG AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.